MEI Pharma, Inc.

NasdaqCM:MEIP Rapporto sulle azioni

Cap. di mercato: US$20.5m

MEI Pharma Salute del bilancio

Salute finanziaria criteri di controllo 6/6

MEI Pharma ha un patrimonio netto totale di $33.0M e un debito totale di $0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente $41.4M e $8.4M. L'EBIT di MEI Pharma è $26.0M rendendo il suo rapporto di copertura degli interessi -7.9. Ha liquidità e investimenti a breve termine pari a $38.3M.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

US$0

Debito

Indice di copertura degli interessi-7.9x
ContantiUS$38.35m
Patrimonio nettoUS$33.02m
Totale passivitàUS$8.36m
Totale attivitàUS$41.38m

Aggiornamenti recenti sulla salute finanziaria

We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

May 18
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Nov 04
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Dec 30
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

Nov 19
Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

May 18
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Mar 26
Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

Feb 12
Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

MEI Pharma: Another PI3K Delta Progressing To The FDA

Feb 01

Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

Dec 02
Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Nov 04
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

MEI Pharma EPS misses by $0.12, misses on revenue

May 06

MEI Pharma promotes Richard Ghalie to chief medical officer

Apr 30

MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued

Apr 26

The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

Feb 25
The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 11
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $40.8M ) di MEIP superano le sue passività a breve termine ( $8.4M ).

Passività a lungo termine: MEIP non ha passività a lungo termine.


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: MEIP è esente da debiti.

Riduzione del debito: MEIP non ha avuto debiti negli ultimi 5 anni.

Copertura del debito: MEIP non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: MEIP non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.


Bilancio


Scoprire le aziende sane